Qualigen therapeutics presents data on qn-247 in triple negative breast cancer at the american association for cancer research (aacr) annual meeting in orlando, fl

In v ivo efficacy study demonstrates qn-247 as potential therapeutic approach in rare breast cancer type
QLGN Ratings Summary
QLGN Quant Ranking